home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

338 rows where filing_period = "second_quarter", filing_year = 2020 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: income_amount, received_date (date)

issue_code 1

  • MED · 338 ✖

filing_year 1

  • 2020 · 338 ✖

filing_period 1

  • second_quarter · 338 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2460493 ATLAS ADVOCACY d8e031b5-0ff6-41b6-bb48-24b7f767ba1f Q2 ATLAS ADVOCACY 401100069 BLADDER CANCER ADVOCACY NETWORK 2020 second_quarter MED CDMRP; Disease Awreness resolution HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2020-06-30T17:47:33.907000-04:00
2460551 FRANCIS EDWARD & CRONIN, INC. fc55f948-2c7a-4858-bea5-8c3328c308a8 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2020 second_quarter MED Issues and legislation related to Alzheimer's disease research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-07-01T09:24:56.350000-04:00
2460554 FRANCIS EDWARD & CRONIN, INC. 14d31ff7-3a95-46a0-8c15-96f518926e6a Q2 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2020 second_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-01T09:28:57.497000-04:00
2460589 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) dcbda974-40a7-47bc-9cf9-007552cec98c Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2020 second_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18700   0 0 2020-07-01T11:00:10.853000-04:00
2460629 OTT BIELITZKI & O'NEILL PLLC 25ddcbe8-78f9-4e22-a459-6f2ae6de4584 Q2 OTT BIELITZKI & O'NEILL PLLC 401103584 BIOPORTO DIAGNOSTICS A/S 2020 second_quarter MED Educating officials about a health care diagnostic tool. Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-07-01T13:15:27.487000-04:00
2460948 BALLARD PARTNERS a113613d-0485-4f6a-8d13-d77cc3f0dd74 Q2 BALLARD PARTNERS 401104288 ORIGIN LOGISTICS, LLC 2020 second_quarter MED Issues related to diagnostic testing for COVID-19. Health & Human Services, Dept of (HHS) 40000   0 0 2020-07-02T17:29:34.363000-04:00
2461070 MARSHALL BRACHMAN f17498ae-9e5b-48c3-8b3f-92b59868149d Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2020 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2020-07-03T11:59:32.487000-04:00
2461404 ISEMAN & ASSOCIATES LLC bf3759e8-2a87-4dc6-91d2-a99e667e0f1d Q2 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2020 second_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-07-06T14:03:24.150000-04:00
2461453 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) adfa0837-e0db-424b-b4b4-56933b6e3227 Q2 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2020 second_quarter MED Funding for COVID treatments and research Funding of federally-sponsored research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research H.R. 3038, "Securing American Science and Technology Act" - provisions related to establishing a system for addressing concerns about foreign influence on research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2020-07-06T15:00:20.730000-04:00
2461457 RUSSELL PUBLIC COMMUNICATIONS 2c27239c-ccdc-418f-9b05-426b193bd3b2 Q2 RUSSELL PUBLIC COMMUNICATIONS 401104398 DIGITAL PATHOLOGY ASSOCIATION 2020 second_quarter MED Urge CMS waiver, in view of pandemic response, to permit remote digital pathology sign-offs Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,White House Office 10000   0 0 2020-07-06T15:13:50.277000-04:00
2461517 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 868d4579-8f39-4f7b-a7c8-845e4a6e23f5 2A MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2020 second_quarter MED Funding for COVID treatments and research Funding of federally-sponsored research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research H.R. 3038, "Securing American Science and Technology Act" - provisions related to establishing a system for addressing concerns about foreign influence on research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2020-07-06T18:00:28.370000-04:00
2461530 THE PETRIZZO GROUP, INC. 651d65d3-4789-4a9f-b940-3ef976fe8e31 Q2 THE PETRIZZO GROUP, INC. 305932 ACCESS TO ADVANCED HEALTH INSTITUTE 2020 second_quarter MED Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; support adjuvant inclusion in COVID-19 countermeasures. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-07-06T19:40:28.183000-04:00
2461554 MUNK POLICY & LAW 61c61d87-0787-4eec-9f92-43dac4190662 Q2 MUNK POLICY & LAW 401105075 SOUTHERN METHODIST UNIVERSITY 2020 second_quarter MED Traumatic Brain Injury Research HOUSE OF REPRESENTATIVES,SENATE,U.S. Geological Survey (USGS) 30000   0 0 2020-07-06T22:48:42.217000-04:00
2461627 AMERICAN COLLEGE OF CLINICAL PHARMACY 370193c2-281b-4443-827d-007bdb2d6238 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2020 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2020-07-07T04:42:14.807000-04:00
2461734 WATKINS & EAGER PLLC 002629c7-839c-4898-a714-38b45e762876 Q2 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2020 second_quarter MED Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-07-07T12:00:23.510000-04:00
2461794 CONGRESSIONAL SOLUTIONS, INC (CSI) 0dff3624-1084-4393-9995-6ca95f402ae5 Q2 CONGRESSIONAL SOLUTIONS, INC (CSI) 297237 UNIVERSITY OF NORTH TEXAS SYSTEM 2020 second_quarter MED COVID19 Research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-07-07T13:20:58.287000-04:00
2461850 BLUEBIRD STRATEGIES 32ee8af9-48fb-44d7-83fe-7dd10ef03fae Q2 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2020 second_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-07T14:13:34.257000-04:00
2461854 BLUEBIRD STRATEGIES fb598e50-07a4-4122-9334-2b2e1eb73d02 Q2 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2020 second_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-07T14:15:38.380000-04:00
2461977 AUBURN HEALTH STRATEGIES, LLC 2d7472b9-8107-4f6e-ae3b-419160d9a9c5 Q2 AUBURN HEALTH STRATEGIES, LLC 292697 NEUROTECH, LLC 2020 second_quarter MED EEG monitoring Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-07T15:40:06.220000-04:00
2462070 SQUIRE PATTON BOGGS 63a45a46-548e-4850-a950-07cc0f11b188 Q2 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2020 second_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-07T16:25:04.657000-04:00
2462510 WINNING STRATEGIES WASHINGTON b29daada-d5c5-4cf4-bd5c-94626beef28b 2T WINNING STRATEGIES WASHINGTON 50796 RISING PHARMA HOLDINGS, INC. 2020 second_quarter MED Distribution of generic pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2020-07-08T14:18:22.133000-04:00
2462612 THE CORMAC GROUP, LLC f063f5f7-85e8-4c3f-9876-dbf78ddcccb3 Q2 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2020 second_quarter MED Appropriations, DOD, TBI research, Veterans Issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-08T17:20:33.833000-04:00
2462759 BEN BARNES GROUP LP 3b3bc387-59c3-4806-8797-66053ee41d6a 2A BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2020 second_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-09T10:12:12.623000-04:00
2462825 SQUIRE PATTON BOGGS 8480ae8e-18ff-4626-97e7-81e06960282e Q2 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2020 second_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2020-07-09T11:24:54.103000-04:00
2462943 THE LIVINGSTON GROUP, LLC e61f3968-44e1-4c53-8967-6db6eed3a060 2T THE LIVINGSTON GROUP, LLC 49635 50 CITIES INC 2020 second_quarter MED Infectious disease prevention.   20000   0 1 2020-07-09T13:03:36.403000-04:00
2462985 FEDERAL SOLUTIONS, LLC 921dfe17-d940-4c9c-8035-afc3f1fdca0c Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2020 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2020-07-09T13:28:10.947000-04:00
2463035 KUTAK ROCK LLP 77cb75d0-b5e1-450d-8852-2da0713e79a0 Q2 KUTAK ROCK LLP 21962 NE ENTERPRISES 2020 second_quarter MED Reauthorization of Pandemic and All Hazards Preparedness Act and related matters   10000   0 0 2020-07-09T14:00:51.290000-04:00
2463051 THE PETRIZZO GROUP, INC. 8ec0426b-98a3-4f8a-b238-8906549e6971 Q2 THE PETRIZZO GROUP, INC. 305932 CEL-SCI CORPORATION 2020 second_quarter MED Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S. 50000   0 0 2020-07-09T14:41:12.077000-04:00
2463062 THE PETRIZZO GROUP, INC. 92e2601e-399b-4e3f-a81d-0f1eb07c4261 Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2020 second_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2020-07-09T14:49:19.820000-04:00
2463064 THE PETRIZZO GROUP, INC. 16060eb3-de11-4e0d-9051-09f01ca3f249 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2020 second_quarter MED Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. The Human Projectome Project, a comprehensive Atlas of cell types in human brain and the Mouse Connectome Project for BRAIN Initiative Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-07-09T14:52:21.003000-04:00
2463127 RAY C CULVER III f2edc2d2-21ae-4ec1-845e-68b0ef3b4dd1 Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2020 second_quarter MED Funding for USDA ARS Human Nutrition Research Centers in the FY2021 House and Senate Agricultural Appropriations bills and finalizing funding for FY20 HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2020-07-09T21:37:10.690000-04:00
2463157 SQUIRE PATTON BOGGS 51f5e857-434c-454c-ab3b-d76c9956c234 Q2 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2020 second_quarter MED National Library of Medicine indexing matters. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-07-10T09:42:41.437000-04:00
2463180 SQUIRE PATTON BOGGS 89fcf09b-e82f-499e-a6a4-8fc3f4fb6d1b Q2 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2020 second_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of,White House Office 80000   0 0 2020-07-10T09:47:56.033000-04:00
2463256 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH ecbcd839-d274-42fd-a682-8cfab07bac11 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2020 second_quarter MED Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   69560 0 0 2020-07-10T10:58:58.117000-04:00
2463341 GOLDBUG STRATEGIES LLC 8f495fe9-5e7d-4eb9-ba1d-797fa3f1d086 Q2 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2020 second_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 19000   0 0 2020-07-10T12:04:39.177000-04:00
2463439 THE JACKSON LABORATORY 5019f127-520a-4e2d-a3b4-4f23a4a28190 Q2 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2020 second_quarter MED Issues pertaining to basic science research and biomedical research. The background and use of animal models in biomedical research. National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations. Issues pertaining to COVID-19 diagnosis and animal model discovery. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   30000 0 0 2020-07-10T13:43:06.773000-04:00
2463765 REPUBLIC CONSULTING, LLC e08a0d9b-0096-4f30-9d8f-f3969077cd59 Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2020 second_quarter MED Monitor Data and Science policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-07-11T12:50:40.997000-04:00
2463843 THE PETRIZZO GROUP, INC. 363005e6-8129-45db-87ff-98b0f746fe17 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2020 second_quarter MED Funding for NIH research; H.R. 4159, PACT Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-07-12T14:54:54.687000-04:00
2464141 WAKE FOREST UNIVERSITY HEALTH SCIENCES a637eea8-e326-4684-bdff-554c02a23742 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2020 second_quarter MED FY21 Department of Labor/HHS Appropriations bill Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2020-07-13T12:41:58.370000-04:00
2464370 STANFORD UNIVERSITY 0666268d-579e-4077-b8c5-7437ea0b16d9 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2020 second_quarter MED HR748 Coronavirus Aid Relief and Economic Security Act of 2020 HR6800 Health and Economic Recovery Omnibus Emergency Solutions Act Reciprocity of Licensing Standards for Health Care Practitioners and Professionals Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)   90000 0 0 2020-07-13T15:35:54.017000-04:00
2464703 AMERICAN PHYSICAL THERAPY ASSOCIATION 209c5d88-63c3-47fb-99be-296b69210e1f Q2 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2020 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention HR 7154 Outpatient Therapy Modernization and Stabilization Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   236490 0 0 2020-07-14T09:37:31.037000-04:00
2464735 AMERICAN PHYSICAL THERAPY ASSOCIATION 413c57ce-e409-4d68-a212-11f20aeaabbc 2A AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2020 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention HR 7154 Outpatient Therapy Modernization and Stabilization Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   236490 0 0 2020-07-14T09:53:36.907000-04:00
2464794 MARSHFIELD CLINIC HEALTH SYSTEM 79b2f996-652d-46ab-9481-f4310d42cd27 Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2020 second_quarter MED General research support, health care quality improvement, precision medicine Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2020-07-14T10:46:53.967000-04:00
2464879 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 218f2d1b-8736-4a99-aac6-4e674989b80f Q2 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2020 second_quarter MED NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues, pediatric research bill HR4519 PACT Act, COVID related testing and research Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   40560 0 0 2020-07-14T11:37:14.437000-04:00
2465144 TODD STRATEGY GROUP 9ea8a8ed-5dd1-49d9-8cf2-ce7fcfc57d01 Q2 TODD STRATEGY GROUP 401103321 BIODESIX, INC. 2020 second_quarter MED FDA regulation of laboratory developed tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-14T14:10:29.973000-04:00
2465276 K&L GATES, LLP 3165eda5-f6d9-4270-b2e5-e995db447e89 Q2 K&L GATES, LLP 32098 NATIONAL ASSN FOR BIOMEDICAL RESEARCH 2020 second_quarter MED Issues related to medical research (no legislation). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Transportation, Dept of (DOT) 20000   0 0 2020-07-14T14:59:19.093000-04:00
2465294 TODD STRATEGY GROUP c05f8afd-2ed8-4351-be78-3812bde95964 Q2 TODD STRATEGY GROUP 401103321 ORGANIZE.ORG 2020 second_quarter MED Organ procurement policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-14T15:03:24.087000-04:00
2465766 MCDERMOTT+ LLC 90294512-29fc-429d-bc5f-420e7ec88e6e Q2 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2020 second_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2020-07-15T10:08:42.967000-04:00
2465844 WINNING STRATEGIES WASHINGTON 4bbbf2ef-ff4e-4d44-9970-248325ccbeee Q2 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2020 second_quarter MED Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-07-15T10:47:05.550000-04:00
2465999 WINNING STRATEGIES WASHINGTON 30459796-566c-45e2-9f4e-91806b47f7a6 Q2 WINNING STRATEGIES WASHINGTON 50796 PHLOW CORPORATION 2020 second_quarter MED Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-15T11:17:36.900000-04:00
2466007 THE PRENDA GROUP LLC 6ab5aa4b-b018-4235-83fa-4ffe4ba48478 Q2 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2020 second_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. CARES ACT HR 748 S 3548 HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE 10000   0 0 2020-07-15T11:18:26-04:00
2466179 WINNING STRATEGIES WASHINGTON bdf8683d-9d11-4dea-a9b9-4b3f595ce17c Q2 WINNING STRATEGIES WASHINGTON 50796 RETRACTABLE TECHNOLOGIES INC (RTI) 2020 second_quarter MED Response to COVID-19 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-15T12:03:04.730000-04:00
2466467 COMMONWEALTH POLICY SOLUTIONS c00cc6db-61b8-438e-88e2-358df6eb35f7 Q2 COMMONWEALTH POLICY SOLUTIONS 401105004 TRISALUS LIFE SCIENCES 2020 second_quarter MED Medical device development for oncology, drug delivery for oncology HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-15T13:49:35.603000-04:00
2466472 COMMONWEALTH POLICY SOLUTIONS 6f8884ed-8ed6-4aba-9533-68bd008a5d4c Q2 COMMONWEALTH POLICY SOLUTIONS 401105004 RARE ACCESS ACTION PROJECT 2020 second_quarter MED Reimbursement for rare disease patient care HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2020-07-15T13:50:37.253000-04:00
2466532 SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN 502cc758-2b76-46f5-8223-34e38ab63488 Q2 SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN 35068 SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN 2020 second_quarter MED Support recognizing construction activities as essential service during pandemic HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-15T14:10:52.473000-04:00
2466652 NEOGENOMICS LABORATORIES 40d08ab4-3c39-4435-8b69-13d686863344 Q2 NEOGENOMICS LABORATORIES 401105014 NEOGENOMICS LABORATORIES 2020 second_quarter MED Verifying Accurate Leading-Edge IVCT Development Act (VALID Act), Draft Legislation HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-07-15T14:38:16.733000-04:00
2466654 THE CONAFAY GROUP, LLC f4009bc0-245a-4252-9a8a-01fc9058892e Q2 THE CONAFAY GROUP, LLC 401004840 HAWAII BIOTECH, INC. 2020 second_quarter MED Medical countermeasures. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-15T14:39:17.903000-04:00
2466884 GREEN PLAINS INC. 9f9ee02b-d97a-4a21-bcb9-c0a5de251955 Q2 GREEN PLAINS INC. 401104765 GREEN PLAINS 2020 second_quarter MED Issues related to the Novel Coronavirus and the disease COVID-19; Issues related to the production of industrial grades of alcohol for inclusion in hand sanitizer; Issues related to the transportation and tax treatment for industrial grades of alcohol for inclusion in hand sanitizer; H.R. 748, the CARES Act; H.R. 6800, the Heroes Act; Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Emergency Management Agency (FEMA),Federal Motor Carrier Safety Administration,Federal Reserve System,Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   180000 0 0 2020-07-15T16:13:18.373000-04:00
2466931 THE CONAFAY GROUP, LLC 3e0b4a0d-1ceb-4631-b793-16c0561db9e9 Q2 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2020 second_quarter MED Pharmaceutical research. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-15T16:25:28.317000-04:00
2466997 THE CONAFAY GROUP, LLC ef6d4a13-1b47-4b2f-b092-1b923ce58726 Q2 THE CONAFAY GROUP, LLC 401004840 EMERGEX VACCINES HOLDING LTD. 2020 second_quarter MED Influenza and respiratory disease research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-15T16:55:51.483000-04:00
2467002 POWERS PYLES SUTTER & VERVILLE, P.C. 9575e367-f481-4d6c-94aa-00bd732f21cd Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 MOSES WEITZMAN HEALTH SYSTEM, INC. 2020 second_quarter MED Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Financial Services and General Government Appropriations Bill House, Senate Community Health Center Reauthorization Bills Pursuit of grants with federal agencies House, Senate Legislation to to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs and Medical Assistant Training Programs House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Health Provider Consultations (E-Consults) with Related Telemedicine in Health Centers and Rural Health Clinics, H.R. 5190 House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 10000   0 0 2020-07-15T16:57:53.227000-04:00
2467006 THE CONAFAY GROUP, LLC f4e251a7-170e-4e47-8d69-aaea1a0f74ab Q2 THE CONAFAY GROUP, LLC 401004840 PREACTIVE TECHNOLOGIES, INC. 2020 second_quarter MED Traumatic Brain Injury Prevention HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-15T17:00:54.473000-04:00
2467026 THE CONAFAY GROUP, LLC 63922695-36b7-4dcf-8960-54501e11e251 2T THE CONAFAY GROUP, LLC 401004840 PHLOW CORPORATION 2020 second_quarter MED US pharmaceutical manufacturing Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2020-07-15T17:14:58.880000-04:00
2467054 THE CONAFAY GROUP, LLC f5ed92db-d68f-40ae-9508-d78544f9d6b0 Q2 THE CONAFAY GROUP, LLC 401004840 CIDARA THERAPEUTICS, INC. 2020 second_quarter MED Support for research on viral diseases HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-15T17:38:10.347000-04:00
2467087 THE CONAFAY GROUP, LLC 62ee4d96-2c83-40cd-9c3b-4030ede3d586 Q2 THE CONAFAY GROUP, LLC 401004840 EMERJA, INC. (FORMERLY KNOWN AS WHEEL BIOLOGY, INC.) 2020 second_quarter MED Seek support for research and development funding Health & Human Services, Dept of (HHS) 10000   0 0 2020-07-15T17:59:19.810000-04:00
2467098 POWERS PYLES SUTTER & VERVILLE, P.C. 58f68ea7-2296-4277-a100-7857674add9e Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2020 second_quarter MED Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Department of Homeland Security Appropriations Bill House, Senate Department of Agriculture Appropriations Bill Pursuit of grants with Federal agencies Telemedicine House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Communications Commission (FCC),Federal Election Commission (FEC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2020-07-15T18:08:21.927000-04:00
2467106 THE CONAFAY GROUP, LLC a4198c42-7633-4277-9bf0-63419f01c7c5 Q2 THE CONAFAY GROUP, LLC 401004840 LUNGPACER MEDICAL USA, INC 2020 second_quarter MED Seek support for research and development funding. Health & Human Services, Dept of (HHS) 10000   0 0 2020-07-15T18:13:24.120000-04:00
2467178 MEHLMAN CONSULTING, INC. 688177c2-c3e0-47ad-a842-2ed67826c1b3 Q2 MEHLMAN CONSULTING, INC. 284950 AEGIS SCIENCES CORPORATION 2020 second_quarter MED H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136; Provisions related to coverage of diagnostic testing Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-15T20:05:46.763000-04:00
2467315 PACE, LLP 3d0f9ac5-26de-48b4-83cf-e1e2526cb8dc Q2 PACE, LLP 30495 GLADSTONE INSTITUTE 2020 second_quarter MED Stem cell research for disease and wound treatments COVID response pollcies Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-16T01:16:20.660000-04:00
2467333 AMERICAN SOCIETY OF ADDICTION MEDICINE f3d543d1-ec57-463e-a469-1a7f5df59aa8 Q2 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2020 second_quarter MED Advocated for FY2021 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, increase in funding for the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, funding for preventive medicine residency programs, and $8.8 billion for discretionary Health Resources and Services Administration programs. Supported HR 3414 (and prior versions)/ S. 2892 - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration… Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   70000 0 0 2020-07-16T07:16:27.093000-04:00
2467693 MCDERMOTT WILL & SCHULTE LLP 3669f4ab-16bd-433c-a127-4bac57bf1d35 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2020 second_quarter MED Issues impacting academic medical centers. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-07-16T10:41:21.857000-04:00
2467733 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 374bce5c-19dd-47c7-8809-8c7d2be962de Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 COLOR HEALTH (FKA COLOR GENOMICS) 2020 second_quarter MED Lobbying related to healthcare issues. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-07-16T10:47:31.067000-04:00
2467832 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) a1b897ad-33de-4b96-9978-6da148e16ca8 Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2020 second_quarter MED Lobbying related to health care issues. SENATE 20000   0 0 2020-07-16T11:04:57.140000-04:00
2467885 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4950397d-04ee-4714-9751-9dba8d93aa2f Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2020 second_quarter MED Research in Endocrinology, Standardization of Hormone Testing Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Special Diabetes Program Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2020-07-16T11:14:10.617000-04:00
2467948 TRAVERE THERAPEUTICS 1348a79c-aa7b-4bee-9edc-6776bdee273b Q2 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2020 second_quarter MED Medical research, NIH funding, related appropriations issues; House and Senate Labor HHS Appropriations Act; FY 2021 CDC Appropriations related to newborn screening; H.R. 478, CARES Act; H.R. 6800, HEROES Act; kidney treatment and care issues Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2020-07-16T11:28:25.487000-04:00
2468104 THE CONAFAY GROUP, LLC 65fd3394-32df-4252-8862-40357b1f2d9f Q2 THE CONAFAY GROUP, LLC 401004840 NABRIVA THERAPEUTICS US, INC. 2020 second_quarter MED Support for medical countermeasure procurement. Health & Human Services, Dept of (HHS)     0 0 2020-07-16T11:58:10.927000-04:00
2468110 TWENTY-FIRST CENTURY GROUP, INC. bad03988-a599-44d5-9516-49137d35fe44 Q2 TWENTY-FIRST CENTURY GROUP, INC. 38687 NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) 2020 second_quarter MED Research and treatment related to suicide prevention for veterans and patients with bipolar depression; COVID-19 research and treatment. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-16T11:59:12.140000-04:00
2468137 TWENTY-FIRST CENTURY GROUP, INC. fc3d44d0-d43d-4773-812b-a723e2ec1d1f Q2 TWENTY-FIRST CENTURY GROUP, INC. 38687 CORNERSTONE PHARMACEUTICALS INC. (FORMERLY RAFAEL PHARMACEUTICALS, INC.) 2020 second_quarter MED Issues related to cancer research and treatment. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-16T12:07:24.160000-04:00
2468178 MICHIGAN TECHNOLOGICAL UNIVERSITY d234012b-2a1b-4f9c-b63a-0bd4ceb92b30 Q2 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2020 second_quarter MED Discussed issues of interest related higher education for the COVID-19 pandemic. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   60000 0 0 2020-07-16T12:15:31.803000-04:00
2468834 THE CONAFAY GROUP, LLC 5447bb98-bc4a-4ea8-b5b6-96d77b8b2ee5 Q2 THE CONAFAY GROUP, LLC 401004840 ATEA PHARMACEUTICALS, INC. 2020 second_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-16T14:15:45.883000-04:00
2468881 THE CONAFAY GROUP, LLC 1f61fa4c-8c44-44ed-807e-9c2d0ba82a71 Q2 THE CONAFAY GROUP, LLC 401004840 CENTIVAX 2020 second_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-16T14:23:04.677000-04:00
2468928 THE CONAFAY GROUP, LLC 80b1d3c2-1a86-495e-a54c-adeff13262cc Q2 THE CONAFAY GROUP, LLC 401004840 PHASEBIO PHARMACEUTICALS, INC 2020 second_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-16T14:30:16.870000-04:00
2469305 CAPITOL COUNSEL LLC a4895781-ce67-4c68-8761-c07d2d69a416 Q2 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2020 second_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-16T15:37:04.017000-04:00
2469318 FAEGRE DRINKER BIDDLE & REATH LLP 98c5a1e2-3964-4dcd-aafe-5c766e4f7c2c Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2020 second_quarter MED Public Health Programs for Infectious and Tropical Disease; Issues related to NIH grant withdrawal for EcoAlliance. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-07-16T15:40:07.300000-04:00
2469384 BURRELL INTERNATIONAL GROUP LLC 7ed6a92d-e92b-467f-8ec2-231221d34af3 Q2 BURRELL INTERNATIONAL GROUP LLC 401103483 SMALL BIOTECHNOLOGY BUSINESS COALITION 2020 second_quarter MED VALID Act and Laboratory Diagnostic Testing HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-16T15:50:29.577000-04:00
2470050 MICHAEL N. MCCARTY LAW OFFICE PLLC fe66608a-7a06-4df3-bd0b-9dea589692e8 Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2020 second_quarter MED Appropriations to CDC for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing supply chain issues. HOUSE OF REPRESENTATIVES,SENATE,White House Office 10000   0 0 2020-07-16T18:48:10.317000-04:00
2470251 WILLIAMS AND JENSEN, PLLC 540876ba-840b-43e2-88db-f99b7a09cbc0 Q2 WILLIAMS AND JENSEN, PLLC 41454 GLOBAL DOWN SYNDROME FOUNDATION 2020 second_quarter MED Support for down syndrome research funding. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-17T05:52:09.007000-04:00
2470311 WILLIAMS AND JENSEN, PLLC 01513d1f-07dc-4633-a851-77273c1d492a Q2 WILLIAMS AND JENSEN, PLLC 41454 BIOBOT ANALYTICS 2020 second_quarter MED General education to advance policies that support wastewater surveillance data analytic technology. Policies impacting U.S. address to the Covid-19 pandemic, including implementation of the H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123; H. R . 6201 Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748 CARES Act, Public Law No: 116-136. Centers For Disease Control & Prevention (CDC),Environmental Protection Agency (EPA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE,White House Office 30000   0 0 2020-07-17T07:02:20.810000-04:00
2470320 WILLIAMS AND JENSEN, PLLC 954b3d8b-691c-4e11-bee8-e8ef6bff182c Q2 WILLIAMS AND JENSEN, PLLC 41454 SANOFI, U.S. 2020 second_quarter MED General education about FDA approval policies and NIH research activities. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2020-07-17T07:04:21.767000-04:00
2470323 WILLIAMS AND JENSEN, PLLC 500c1f4b-dbbf-42d8-ad5c-013973dd2ab0 Q2 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2020 second_quarter MED General education about FDA approval policies and NIH research activities. Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2020-07-17T07:05:22.480000-04:00
2470450 MANATOS & MANATOS 5dbd4380-29fb-435f-aa77-a88016b963ca Q2 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2020 second_quarter MED PPS-exempt cancer hospitals HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-07-17T09:11:59.170000-04:00
2470533 TWENTY-FIRST CENTURY GROUP, INC. 071c24a6-0bcd-4729-89fa-e655d52437f3 Q2 TWENTY-FIRST CENTURY GROUP, INC. 38687 GLOBAL ALZHEIMER'S PLATFORM FOUNDATION 2020 second_quarter MED Inform Congress about the impact of COVID-19 on Alzheimer's clinical trials. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2020-07-17T09:30:16.150000-04:00
2470589 BRACEWELL LLP a3d747b6-3fbf-41c6-9893-e82aa802180b Q2 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2020 second_quarter MED work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-07-17T09:47:29.663000-04:00
2470687 EFB ADVOCACY, LLC fd4050dc-b39b-406b-bd0b-aa3e42204947 Q2 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2020 second_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-17T10:05:49.977000-04:00
2471079 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 23a68576-3663-49a1-bc71-ec5652fd3966 Q2 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 401104196 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 2020 second_quarter MED NIH funding for aging science, tobacco and peer review activities Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2020-07-17T11:16:20.840000-04:00
2471175 FAEGRE DRINKER BIDDLE & REATH LLP cd60bfd0-4101-4284-a6fc-b981da0feed8 Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2020 second_quarter MED Issues related to anti-microbial resistance and neglected tropical diseases; CURES 2.0 legislative initiative; Access and affordability of COVID-19 treatments and vaccines; Draft PASTEUR Act legislation.   10000   0 0 2020-07-17T11:30:42.790000-04:00
2471180 FAEGRE DRINKER BIDDLE & REATH LLP b5fbeb44-7f88-4022-a2fc-f822d426dfae Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH 2020 second_quarter MED Cures 2.0.; PASTEUR Act legislative draft.   10000   0 0 2020-07-17T11:31:44.433000-04:00
2471308 ALLIANCE FOR RETIRED AMERICANS 7ae74f67-7343-4ea1-b6d4-0b65a7e2dde7 Q2 ALLIANCE FOR RETIRED AMERICANS 67238 ALLIANCE FOR RETIRED AMERICANS 2020 second_quarter MED 1. S. 3847, COVID-19 Emergency Manufacturing Act of 2020, entire bill Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Pension & Welfare Benefits Administration,SENATE,Social Security Administration (SSA),U.S. Trade Representative (USTR)   80000 0 0 2020-07-17T11:52:19.267000-04:00
2471443 UNIVERSITY OF IOWA c393b01b-01b8-4aac-b7e8-70bf9a997b25 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2020 second_quarter MED Support for robust funding for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   70000 0 0 2020-07-17T12:07:48.827000-04:00
2471554 DLA PIPER LLP (US) 64962912-bf5b-4a2f-93c7-44cc0cbbb08c Q2 DLA PIPER LLP (US) 76855 AMERIHEALTH CARITAS 2020 second_quarter MED Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-07-17T12:19:19.263000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2548.395ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API